Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy - Wikidata - awgldk - TriplyDB

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy

http://www.wikidata.org/entity/Q37277601

about

Oxidant Mechanisms in Renal Injury and Disease Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus.Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans.Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study).Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes Intratubular renin-angiotensin system in hypertension Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes.Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies.The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes.Role of stimulated intrarenal angiotensinogen in hypertension.Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.Angiotensin II blockade and renal protection.Oxidative stress in diabetic nephropathy.Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients.Nitrosonifedipine ameliorates the progression of type 2 diabetic nephropathy by exerting antioxidative effects.Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5.

P2860

Q28384392-F1311366-C6BE-4ECD-B090-5F51C8FAF1DA Q33559001-AD34D1DC-E64B-45E3-95BA-B0EC81B9DAF0 Q33585798-53752FBB-1349-443F-9E4E-AB26A2E8078E Q33716378-4F8F2131-DC0F-437D-8EF1-F3747C1423DC Q33902878-6A7427D2-6C15-4C45-9B03-5FED52B5FBE7 Q33940516-AD17045D-9297-48EE-BE97-1B8A26094531 Q34416954-4F8BD827-791F-4D1B-A94D-1EBF9BCE79F0 Q34777649-45085B4F-5FE4-47D7-A45F-ADA50D26FF0C Q35227691-D23A4272-093F-4D1F-9174-78BEFB29D459 Q35663915-F107C717-E834-4011-9DCE-83620BE70555 Q35802311-8BC85CBC-6C46-42BF-AC74-E755D9A28CC4 Q35828486-D21AC90F-72DD-4022-97D3-321BBE440775 Q35916243-9C990FBB-AE93-477D-AA0B-559DC142BE91 Q36029685-B16E8D7D-934E-494D-A52C-4FB7FACC6697 Q36035037-9D4FE357-D66B-47B7-BD73-EA8F062A4C04 Q36219052-4D58E4C5-E423-4531-98DA-30FB6D863F43 Q36236725-38B734A4-6523-4920-900C-DC01656F78A7 Q36449123-1964E85B-E5EE-445E-A06F-3907E76D09C9 Q36561841-171658E5-F4E2-4133-BE85-6D16DB0E7202 Q36836004-8B9A13DC-D450-4BEC-A9A9-F0F7C01CCDFC Q37003803-5AFC5BC8-1B85-4D19-81E2-81C72BAEFFAD Q37375567-4FE378EC-64C9-40C8-9A96-4ECF3099A5EA Q37465388-A3A0BF2A-F1D4-4CBD-9085-A71AF3FA1198 Q37525237-57E65417-CB51-47EC-AA26-0D576A235E83 Q37740463-1B9CCF3F-507A-452F-A17C-9945A12CB1F6 Q41104232-0DF732ED-33C4-4923-9281-19A33950878F Q42084094-11AAF021-74B9-4FD6-94BD-69C28D8E7DB1 Q45326481-D94C10A0-D89A-424D-9D20-665FE6732B84 Q47137843-D6AE686D-5952-4F7D-AD17-DB4E549EBDE2

P2860

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy

http://www.wikidata.org/entity/Q37277601

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Angiotensin II Type 1 Receptor ...... th Type 2 Diabetic Nephropathy

@en

Angiotensin II Type 1 Receptor ...... h Type 2 Diabetic Nephropathy.

@nl

type

label

Angiotensin II Type 1 Receptor ...... th Type 2 Diabetic Nephropathy

@en

Angiotensin II Type 1 Receptor ...... h Type 2 Diabetic Nephropathy.

@nl

prefLabel

Angiotensin II Type 1 Receptor ...... th Type 2 Diabetic Nephropathy

@en

Angiotensin II Type 1 Receptor ...... h Type 2 Diabetic Nephropathy.

@nl

P1433

Q37277601-974A83BA-6430-4195-A51F-2AC07AB4ABBA

P1476

Q37277601-11DD0055-23C7-449C-B1F0-D0A6C3520D6F

P2093

Q37277601-0C3DBA45-BA60-46DF-BC24-963D37A67C16

Q37277601-1E5D8718-F73F-4001-B6C9-0265CBF6DFAB

Q37277601-2A8D47FC-E59B-4DC2-B603-3A47C467D104

Q37277601-4D44CD99-7481-4B09-B43A-BEEF9DF65D65

Q37277601-64639DB4-D71D-457A-BAA4-3B399D45BD7D

Q37277601-D0B438A7-6348-4F09-A247-AB73618B3DFB

Q37277601-DA349E0E-318B-43B5-8812-3774894D4E42

Q37277601-DBB08B92-894D-4078-9C28-A7918774616A

Q37277601-ED3C9245-CB97-4807-A800-06BA7FAB14C8

P2860

Q37277601-10213C50-659D-4168-9B1D-BAB2C8DF5C0A

Q37277601-332D8CAC-E1A9-408F-AD7F-E28FF65CDCD0

Q37277601-38FFA7A2-B916-4C71-A881-2A04BA271184

Q37277601-5E0631B9-9CA1-4E53-ABFD-11ECA0C1EAE8

Q37277601-5FE38BC3-1693-406E-B678-D52645E8CB00

Q37277601-A26D75FA-2902-4566-BD0A-D3E91C5CD185

Q37277601-B88B5968-15B1-486D-A3DA-5BABBDB64497

Q37277601-BDEF31DE-C9B6-4563-8795-15E1E9EC3A06

Q37277601-D1EBFA02-71B3-4410-AB3D-C8FD331CFA57

Q37277601-E58A5729-D28C-4F11-A104-125EC21190DC

P304

Q37277601-2DCB1B83-5C46-4776-9210-A83F3E452A2F

P31

Q37277601-1BC6B20E-AC89-4C09-9DE6-EF2CF6FE19C4

P356

Q37277601-74E78A62-CB66-4D6B-87F7-E788E0AEBD26

P478

Q37277601-A30B883F-BF4D-4407-B382-127B0295652E

P577

Q37277601-70C895DA-F1CE-45AE-BC97-03FEAC27B26C

P698

Q37277601-55B8619E-7EF4-43FC-A668-8AAD13587FA0

P921

Q37277601-338967EB-9A7A-4C50-955A-D08795B19A36

Q37277601-95A55B55-BA64-45D8-A015-81BC56B21947

P932

Q37277601-D74BA660-F40C-4C86-AA8E-F42E37A17145

P356

P1433

Biomarker Insights

P1476

Angiotensin II Type 1 Receptor ...... th Type 2 Diabetic Nephropathy

@en

P2093

Akira Nishiyama

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kobori

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Nako

http://www.w3.org/2001/XMLSchema#string

Maki Urushihara

http://www.w3.org/2001/XMLSchema#string

Naro Ohashi

http://www.w3.org/2001/XMLSchema#string

Sadayoshi Ito

http://www.w3.org/2001/XMLSchema#string

Susumu Ogawa

http://www.w3.org/2001/XMLSchema#string

Takefumi Mori

http://www.w3.org/2001/XMLSchema#string

Tsuneo Ishizuka

http://www.w3.org/2001/XMLSchema#string

P2860

High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells

High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells

New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.

Novel sandwich ELISA for human angiotensinogen

Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases

Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients

High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells.

A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.

Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells.

Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy.

P304

97-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/BMI.S2733

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19652765

http://www.w3.org/2001/XMLSchema#string

P921

P932

2716676

http://www.w3.org/2001/XMLSchema#string